-
-
-
-
-
-
-
Synopsys upgrade bets on FY27 growth rebound and stronger chip-design demand
-
-
-
-
-
-
-
Benchmark initiates Synopsys, Cadence with Buy ratings on AI-driven EDA outlook
-
-
-
-
-
-
-
Synopsys earnings preview: BofA sees beat-and-raise as EDA demand broadens
-
-
-
-
-
-
-
Synopsys Posts Financial Results for First Quarter Fiscal Year 2026
-
-
-
-
-
-
-
Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea Holdings, Inc. (NASDAQ: FTRE); Molina Healthcare, Inc. (NYSE: MOH); and Synopsys, Inc. (NASDAQ: SNPS): Grabar Law Office
-
-
-
-
-
-
-
Attention Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea Holdings, Inc. (NASDAQ: FTRE); Synopsys, Inc. (NASDAQ: SNPS); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law O
-
-
-
-
-
-
-
Synopsys, Inc. Securities Fraud Class Action Result of Financial Issues and +34% Stock Decline - Investors may Contact Lewis Kahn, Esq, @ KSF
-
1,232,933 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


